Handelsbanken Fonder AB Lowers Stock Holdings in ICON Public Limited (NASDAQ:ICLR)

Handelsbanken Fonder AB decreased its position in shares of ICON Public Limited (NASDAQ:ICLR) by 4.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,676 shares of the medical research company’s stock after selling 1,033 shares during the period. Handelsbanken Fonder AB’s holdings in ICON Public were worth $4,336,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Kornitzer Capital Management Inc. KS raised its position in ICON Public by 40.6% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 97,102 shares of the medical research company’s stock valued at $20,363,000 after purchasing an additional 28,050 shares in the last quarter. Foyston Gordon & Payne Inc purchased a new stake in ICON Public during the third quarter valued at about $11,672,000. Icon Wealth Advisors LLC raised its position in ICON Public by 861.1% during the third quarter. Icon Wealth Advisors LLC now owns 13,215 shares of the medical research company’s stock valued at $3,797,000 after purchasing an additional 11,840 shares in the last quarter. Entropy Technologies LP raised its position in ICON Public by 472.2% during the fourth quarter. Entropy Technologies LP now owns 6,174 shares of the medical research company’s stock valued at $1,295,000 after purchasing an additional 5,095 shares in the last quarter. Finally, Tributary Capital Management LLC raised its position in ICON Public by 116.1% during the fourth quarter. Tributary Capital Management LLC now owns 3,950 shares of the medical research company’s stock valued at $828,000 after purchasing an additional 2,122 shares in the last quarter. Hedge funds and other institutional investors own 95.61% of the company’s stock.

ICON Public Stock Down 0.2 %

NASDAQ ICLR opened at $201.39 on Monday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.26 and a quick ratio of 1.34. The stock has a market capitalization of $16.61 billion, a PE ratio of 21.13, a PEG ratio of 1.86 and a beta of 1.19. ICON Public Limited has a 1 year low of $181.51 and a 1 year high of $347.72. The business’s 50-day moving average is $202.90 and its 200 day moving average is $244.47.

ICON Public (NASDAQ:ICLR) last posted its earnings results on Wednesday, February 19th. The medical research company reported $3.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.41 by $0.01. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.04 billion. ICON Public had a return on equity of 11.81% and a net margin of 9.56%. Sell-side analysts forecast that ICON Public Limited will post 13.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ICLR shares. William Blair restated an “outperform” rating on shares of ICON Public in a research report on Tuesday, January 14th. Royal Bank of Canada reiterated an “outperform” rating and issued a $263.00 price objective on shares of ICON Public in a report on Wednesday, January 15th. Robert W. Baird decreased their price objective on ICON Public from $249.00 to $225.00 and set a “neutral” rating on the stock in a report on Wednesday, November 20th. Truist Financial decreased their price objective on ICON Public from $284.00 to $262.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Finally, Citigroup decreased their price objective on ICON Public from $300.00 to $290.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $281.00.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.